Pelagos Pharma

Houston, United States Founded: 2015 • Age: 11 yrs
Therapeutics are developed to modulate cellular metabolism for complex diseases.

About Pelagos Pharma

Pelagos Pharma is a company based in Houston (United States) founded in 2015 by Thomas Burris.. Pelagos Pharma offers products and services including Exercise Mimetic Drugs and Therapeutic Treatments.

  • Headquarter Houston, United States
  • Founders Thomas Burris
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pelagos Pharmaceuticals Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $466.72 K (USD), Grant

    Aug 17, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pelagos Pharma

Pelagos Pharma offers a comprehensive portfolio of products and services, including Exercise Mimetic Drugs and Therapeutic Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Drugs are being developed to activate metabolic and mitochondrial pathways for diseases of aging

Treatments are provided for aging-related diseases through the activation of exercise-related pathways

Funding Insights of Pelagos Pharma

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $466,719
  • First Round

    (17 Aug 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2022 Amount Grant - Pelagos Pharma Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pelagos Pharma

Pelagos Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pelagos Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pelagos Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pelagos Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pelagos Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pelagos Pharma

Frequently Asked Questions about Pelagos Pharma

When was Pelagos Pharma founded?

Pelagos Pharma was founded in 2015 and raised its 1st funding round 7 years after it was founded.

Where is Pelagos Pharma located?

Pelagos Pharma is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Who is the current CEO of Pelagos Pharma?

Dirk Verstoep is the current CEO of Pelagos Pharma.

What does Pelagos Pharma do?

Founded in 2015 and based in Houston, United States, therapeutics are developed by Pelagos Pharma to modulate cellular metabolism and target diseases such as obesity, heart failure, and age-related disorders. Drugs are offered that activate metabolic and mitochondrial pathways, with operations focused on understanding the role of cellular metabolism in these conditions. The biotechnology sector is served through research and drug development efforts.

What products or services does Pelagos Pharma offer?

Pelagos Pharma offers Exercise Mimetic Drugs and Therapeutic Treatments.

Who are Pelagos Pharma's investors?

Pelagos Pharma has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available